Evidence map›Paper›PMID 19403637›Full record

Trial reportThe American journal of clinical nutrition2009

Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults.

Gerald F Combs, Douglas N Midthune, Kristine Y Patterson, Wesley K Canfield, A David Hill, Orville A Levander, Philip R Taylor, James E Moler, Blossom H Patterson

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Review
  17. Features of selenium metabolism in humans living under the conditions of North European Russia.International archives of occupational and environmental health · 2014
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Gerald F CombsGrand Forks Human Nutrition Research Center, US Department of Agriculture, Agricultural Research Service, Grand Forks, ND 55202, USA. gerald.combs@ars.usda.gov
Douglas N Midthune
Kristine Y Patterson
Wesley K Canfield
A David Hill
Orville A Levander
Philip R Taylor
James E Moler
Blossom H Patterson
Agricultural Research Service · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

backgroundSelenium, a potential cancer prevention agent currently being tested against prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT), plays an integral role in thyroid metabolism. The effects of long-term selenium supplementation on thyroid hormone concentrations are unknown.

objectiveThe objective was to investigate the effects of long-term selenium supplementation on thyroid hormone concentrations.

designTwenty-eight healthy adults took 200 microg selenomethionine/d for 28 mo. The thyroid hormones triiodothyronine (T3), thyroxine (T4), and thyrotropin (TSH) were measured in plasma for 4 mo before supplementation and quarterly during supplementation. The assay methods were changed midstudy; the results of the 2 methods were not comparable. Therefore, one analysis was conducted based on the results of the first method, and a second analysis was based on all of the data, adjusted for the change. Serial data collection permitted a test for trends rather than simply a difference between initial and final values.

resultsBy 9 mo, mean (+/-SEM) plasma selenium concentrations had increased from 1.78 +/- 0.07 micromol/L at baseline to 2.85 +/- 0.11 micromol/L for men and from 1.64 +/- 0.04 to 3.32 +/- 0.1.2 micromol/L for women. T3 concentrations in men increased 5% per year (P = 0.01). T4 and TSH concentrations were unchanged.

conclusionsSelenium supplementation produced no clinically significant changes in thyroid hormone concentrations. A small but statistically significant increase in T3 concentrations was noted in men, with no corresponding decreases in TSH. A subset of SELECT subjects might be monitored periodically for changes during long-term selenium supplementation.

Indexed as

Dietary SupplementsAdultFemaleHumansMaleMiddle AgedSeleniumSelenomethionineSex FactorsThyrotropinThyroxineTrace ElementsTriiodothyronineSeleniumSelenomethionineThyrotropinThyroxineTrace ElementsTriiodothyronine

Identifiers

PMID19403637
PMCPMC2682996
OpenAlexW2110140636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.